Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FRW91
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,335
Award facts
- Contract value 100% obligated
- $9,334.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $9,334.98. The award is competitively bid with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. This delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government.
This award is issued as a child contract under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, utilizes this prime contract vehicle to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems worldwide. The delivery order for RINVOQ, a prescription medication used in treating inflammatory conditions, reflects the company's established capability to fulfill federal medical procurement requirements through competitive processes and demonstrates the operational efficiency of the DLA's pharmaceutical supply chain model.
Quick answers
Who was awarded contract SPE2DB25FRW91?
SPE2DB25FRW91 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FRW91 worth?
The government has obligated $9,335 on SPE2DB25FRW91.
Is contract SPE2DB25FRW91 an order under another contract?
Yes. SPE2DB25FRW91 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRW91 competed?
The extent of competition for SPE2DB25FRW91 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award